Search
Medicus Pharma Ltd
MDCXAdd to Watchlist
0.275USD
+0.013+4.80%
Close 07-31 16:00（ET）Quotes delayed by 15 min
11.01MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
4
analysts
Buy
Current Rating
4.500
Target Price
+1566.67%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Medicus Pharma Ltd
MDCX
4
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Medicus Pharma Ltd's price target?
Analysts forecast that Medicus Pharma Ltd's price target is USD 20.00, with the highest forecast at USD 27.00 and the lowest forecast at USD 20.00.
How have Medicus Pharma LtdMDCX's recent earnings per share performed?
The market expectation was USD -0.31, while Medicus Pharma LtdMDCX's earnings per share (EPS) for the previous quarter was USD -0.81. EPS for the next quarter is expected at USD -0.13.
What is the analyst rating for Medicus Pharma Ltd?
Based on the ratings of Medicus Pharma Ltd's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.